Novavax Inc (NVAX) Return on Investment ROI from the first quarter of 2026 to first quarter of 2025 and for the year 2026, average high and low, overall ranking from Mar 31 2026 to Mar 31 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Novavax inc   (NASDAQ: NVAX)


Novavax Inc's ROI from its first quarter of 2026 to the first quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Novavax Inc's ROI in the first quarter of 2026?
Novavax Inc recorded a cumulative net loss of $-88 million during 12 months ending in the first quarter of 2026, resulting in a negative return on investment (ROI) of -11.28%.

Within the Healthcare sector 285 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2025 from 75 to 3067.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Investment Change TTM 26.14 % 52.96 % 56.23 % 76.55 % 149.69 %
Y / Y Net Income Change TTM - - - 2750.95 % -
Investment (TTM) in Millions 701 717 750 947 871
Return On Investment (TTM) -11.28 % 53.62 % 45.96 % 61.37 % 77.55 %
NVAX's Overall Ranking # 3067 # 75 # 35 # 62 # 32
Seq. Investment Change TTM -5.18 % 10.44 % 7.93 % 11.61 % 14.98 %
Seq. Net Income Change TTM - 28.84 % -19.18 % -11.67 % -
Net Income (TTM) in Millions -88 440 342 423 479

NVAX Company Profile >> Back to NVAX Roi Comparisons >> See Annual NVAX Return On Investment



Return On Investment NVAX's Ranking
Within: No.
Industry # 30
Sector # 286
Overall # 3067

Return On Investment Statistics
High Average Low
71.31 %
-113.97 %
-997.49 %
(Mar 31 2025)   (Jun 30 2023)







Financial Statements
Novavax Inc's I. Quarter Investments $ 701 Millions NVAX's Balance sheet
Novavax Inc's I. Quarter Income $ -9 Millions Quarterly NVAX's Income Statement
NVAX's Income by Division See NVAX's Income by Division


NVAX Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 717 406 162 -201 186
Y / Y Investment Growth 76.49 % 150.08 % - - -80.41 %
Net Income in Millions 440 -187 -545 -658 -1,744
Y / Y Net Income Growth - - - - -
Annual Return On Investment 61.45 % -46.18 % -335.73 % - -935.32 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 61.45 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
NVAX's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for NVAX's Competitors
Subscribers only: Roi for Novavax Inc's Suppliers
Subscribers only: Return On Investment for NVAX's Customers

Other Ratios
NVAX's Roa NVAX's Inventory Turnover Ratio NVAX's Growth Rates NVAX's Dividend Statistics
NVAX's Profitability Ratios NVAX's Asset Turnover Ratio NVAX's Dividend Growth
NVAX's Roe NVAX's Valuation Ratios NVAX's Financial Strength Ratios NVAX's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2026, within Healthcare Sector ROI

Date modified: 2026-08-30T14:38:12+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.